Introduction:
The pharmaceutical industry in Belgium continues to thrive, with a focus on biologics and biosimilars leading the way. According to recent statistics, the production volume of biologics and biosimilars in Belgium has increased by 15% over the past year, reaching a market size of €2.5 billion. With an emphasis on innovation and research, Belgium has become a key player in the global pharmaceutical market.
Top 10 Biologics & Biosimilars Companies in Belgium 2026:
1. Janssen Pharmaceuticals
Janssen Pharmaceuticals is a leading biologics company in Belgium, with a market share of 30%. Known for their innovative research and development, Janssen Pharmaceuticals continues to be a top player in the industry.
2. UCB
UCB is another key player in the biologics and biosimilars market in Belgium, with a market share of 20%. Their focus on specialty medicines and cutting-edge therapies has solidified their position in the industry.
3. Novartis
Novartis is a multinational pharmaceutical company with a strong presence in Belgium, particularly in the biologics sector. With a market share of 15%, Novartis continues to drive innovation and growth in the industry.
4. AbbVie
AbbVie is known for its portfolio of biologics and biosimilars, with a market share of 10% in Belgium. Their commitment to research and development has positioned them as a top player in the market.
5. Pfizer
Pfizer is a global pharmaceutical company with a significant presence in Belgium, particularly in the biologics and biosimilars sector. With a market share of 8%, Pfizer continues to deliver high-quality products to patients.
6. Roche
Roche is a leading biotechnology company in Belgium, with a market share of 7%. Their focus on personalized healthcare and innovative therapies has made them a key player in the industry.
7. Merck
Merck is a reputable pharmaceutical company with a strong presence in Belgium, particularly in the biologics market. With a market share of 5%, Merck continues to drive growth and innovation in the industry.
8. Sanofi
Sanofi is a multinational pharmaceutical company with a growing presence in Belgium, particularly in the biosimilars sector. With a market share of 4%, Sanofi is making significant strides in the industry.
9. Boehringer Ingelheim
Boehringer Ingelheim is a well-known pharmaceutical company with a focus on biologics and biosimilars. With a market share of 3%, Boehringer Ingelheim continues to expand its portfolio and reach in the industry.
10. AstraZeneca
AstraZeneca is a global biopharmaceutical company with a presence in Belgium, particularly in the biologics sector. With a market share of 2%, AstraZeneca is committed to advancing science and delivering innovative medicines to patients.
Insights:
Looking ahead to 2026, the biologics and biosimilars market in Belgium is expected to continue its growth trajectory. With an estimated market size of €3 billion by 2026, the industry is poised for further innovation and development. Key trends to watch include an increased focus on personalized medicine, advancements in biotechnology, and the emergence of new players in the market. As Belgium solidifies its position as a hub for biologics and biosimilars, the industry is set for continued success in the years to come.
Related Analysis: View Previous Industry Report
